Nomura Asset Management CO LTD Celldex Therapeutics, Inc. Transaction History

Nomura Asset Management CO LTD

  • $31.8 Billion
  • Q3 2024
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$32.06 - $44.56 $0 - $0
0 New
0 $0
Q2 2024

Aug 14, 2024
BUY
$32.76 - $42.56 $0 - $0
0 New
0 $0
Q1 2024

May 13, 2024
BUY
$35.22 - $51.88 $0 - $0
0 New
0 $0
Q4 2023

Feb 09, 2024
BUY
$22.61 - $40.65 $0 - $0
0 New
0 $0
Q3 2023

Nov 03, 2023
BUY
$25.45 - $37.46 $0 - $0
0 New
0 $0
Q2 2023

Aug 14, 2023
BUY
$30.29 - $38.28 $0 - $0
0 New
0 $0
Q1 2023

May 11, 2023
BUY
$34.78 - $47.43 $0 - $0
0 New
0 $0

Others Institutions Holding CLDX

# of Institutions
207
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.2B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email